![Andrew Newland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Newland
Gründer bei
Novocellus Ltd.
Vermögen: 211 690 $ am 31.05.2026
Profil
Mr. Andrew D.
Newland is a Chairman at NeuroTargets Ltd., a Chairman at Novocellus Ltd. and a Chairman at Parsortix, Inc. He is on the Board of Directors at ANGLE Europe Ltd. and Arenko Cleantech Ltd. Mr. Newland was previously employed as a Chief Executive Officer by ANGLE Plc, a Chairman by Provexis Ltd., and a Chairman by Acolyte Biomedica Ltd. He received his graduate degree from the University of Cambridge.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CELLBXHEALTH PLC 0.64% | 31.12.2025 | 7’304’686 ( 0.64% ) | 211 690 $ | 31.05.2026 |
Aktive Positionen von Andrew Newland
| Unternehmen | Position | Beginn |
|---|---|---|
NeuroTargets Ltd.
 NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutic products | Vorsitzender | - |
Novocellus Ltd. | Gründer | - |
Parsortix, Inc. | Vorsitzender | - |
Arenko Cleantech Ltd.
 Arenko Cleantech Ltd. Engineering & ConstructionIndustrial Services Builds, owns and operates energy storage assets | Direktor/Vorstandsmitglied | - |
ANGLE Europe Ltd.
 ANGLE Europe Ltd. Internet Software/ServicesTechnology Services Operates as a technology platform that captures cells circulating in blood | Direktor/Vorstandsmitglied | 26.04.2006 |
Ehemalige bekannte Positionen von Andrew Newland
| Unternehmen | Position | Ende |
|---|---|---|
| CELLBXHEALTH PLC | Gründer | 12.09.2025 |
Provexis Ltd.
 Provexis Ltd. BiotechnologyHealth Technology Develops and produces natural bioactive ingredients | Vorsitzender | 01.01.2005 |
Acolyte Biomedica Ltd.
 Acolyte Biomedica Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures, and markets microbiology and cell enumeration systems | Gründer | - |
Ausbildung von Andrew Newland
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
25
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
CelLBxHealth Plc
 CelLBxHealth Plc Medical DistributorsDistribution Services Operates as a holding company with interests in providing products in cancer diagnostics and foetal health | Distribution Services |
Provexis Ltd.
Provexis Ltd. BiotechnologyHealth Technology Develops and produces natural bioactive ingredients | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acolyte Biomedica Ltd.
Acolyte Biomedica Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures, and markets microbiology and cell enumeration systems | Commercial Services |
NeuroTargets Ltd.
NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutic products | Health Technology |
Novocellus Ltd. | |
Parsortix, Inc. | |
Arenko Cleantech Ltd.
Arenko Cleantech Ltd. Engineering & ConstructionIndustrial Services Builds, owns and operates energy storage assets | Industrial Services |
ANGLE Europe Ltd.
ANGLE Europe Ltd. Internet Software/ServicesTechnology Services Operates as a technology platform that captures cells circulating in blood | Technology Services |
Wählen Sie MarketScreener 
